ASKA Pharmaceutical HoldingsLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
ASKA Pharmaceutical HoldingsLtd has a total shareholder equity of ¥63.3B and total debt of ¥8.3B, which brings its debt-to-equity ratio to 13.1%. Its total assets and total liabilities are ¥87.3B and ¥24.0B respectively. ASKA Pharmaceutical HoldingsLtd's EBIT is ¥6.6B making its interest coverage ratio -25.9. It has cash and short-term investments of ¥14.0B.
Anahtar bilgiler
13.1%
Borç/özkaynak oranı
JP¥8.27b
Borç
| Faiz karşılama oranı | -25.9x |
| Nakit | JP¥14.02b |
| Eşitlik | JP¥63.33b |
| Toplam yükümlülükler | JP¥23.99b |
| Toplam varlıklar | JP¥87.32b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 4886's short term assets (¥52.0B) exceed its short term liabilities (¥19.5B).
Uzun Vadeli Yükümlülükler: 4886's short term assets (¥52.0B) exceed its long term liabilities (¥4.5B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 4886 has more cash than its total debt.
Borcun Azaltılması: 4886's debt to equity ratio has reduced from 48.3% to 13.1% over the past 5 years.
Borç Kapsamı: 4886's debt is not well covered by operating cash flow (18%).
Faiz Kapsamı: 4886 earns more interest than it pays, so coverage of interest payments is not a concern.